Cecilia Chaparro

7.9k total citations · 1 hit paper
118 papers, 4.7k citations indexed

About

Cecilia Chaparro is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Transplantation. According to data from OpenAlex, Cecilia Chaparro has authored 118 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Surgery, 49 papers in Pulmonary and Respiratory Medicine and 31 papers in Transplantation. Recurrent topics in Cecilia Chaparro's work include Transplantation: Methods and Outcomes (93 papers), Cystic Fibrosis Research Advances (27 papers) and Renal Transplantation Outcomes and Treatments (26 papers). Cecilia Chaparro is often cited by papers focused on Transplantation: Methods and Outcomes (93 papers), Cystic Fibrosis Research Advances (27 papers) and Renal Transplantation Outcomes and Treatments (26 papers). Cecilia Chaparro collaborates with scholars based in Canada, United States and Switzerland. Cecilia Chaparro's co-authors include Shaf Keshavjee, L.G. Singer, Michael Hutcheon, Thomas K. Waddell, Steven Kesten, Marc de Perrot, Chung‐Wai Chow, Masaaki Sato, Denis Hadjiliadis and Mingyao Liu and has published in prestigious journals such as New England Journal of Medicine, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

In The Last Decade

Cecilia Chaparro

113 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Normothermic Ex Vivo Lung Perfusion in Clinical Lung Transplantation

2011 739 citations Marcelo Cypel, Jonathan Yeung et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cecilia Chaparro Canada	34	3.6k	1.9k	1.2k	969	762	118	4.7k
Stuart C. Sweet United States	36	2.7k 0.7×	1.3k 0.7×	1.1k 0.9×	712 0.7×	659 0.9×	124	3.9k
Denis Hadjiliadis United States	37	2.5k 0.7×	2.3k 1.2×	654 0.5×	894 0.9×	429 0.6×	123	4.5k
Gregory I. Snell Australia	35	4.7k 1.3×	2.6k 1.4×	1.6k 1.3×	991 1.0×	1.1k 1.5×	168	6.2k
Aldo Iacono United States	39	2.3k 0.6×	1.2k 0.6×	1.2k 1.0×	963 1.0×	481 0.6×	130	3.9k
Jonathan B. Orens United States	40	3.4k 0.9×	2.5k 1.3×	1.0k 0.8×	798 0.8×	949 1.2×	130	5.4k
Christiane Knoop Belgium	32	1.7k 0.5×	1.7k 0.9×	677 0.6×	767 0.8×	277 0.4×	104	3.4k
Christian A. Merlo United States	36	1.7k 0.5×	1.9k 1.0×	624 0.5×	766 0.8×	334 0.4×	158	3.9k
G. Warnecke Germany	37	3.2k 0.9×	1.3k 0.7×	933 0.8×	567 0.6×	1.7k 2.3×	272	5.1k
James H. Dauber United States	46	2.7k 0.7×	2.8k 1.5×	967 0.8×	1.6k 1.7×	303 0.4×	136	6.1k
M. Crespo United States	32	2.2k 0.6×	852 0.5×	717 0.6×	1.1k 1.1×	880 1.2×	111	3.5k

Countries citing papers authored by Cecilia Chaparro

Since Specialization

Citations

This map shows the geographic impact of Cecilia Chaparro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Chaparro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Chaparro more than expected).

Fields of papers citing papers by Cecilia Chaparro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilia Chaparro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Chaparro. The network helps show where Cecilia Chaparro may publish in the future.

Co-authorship network of co-authors of Cecilia Chaparro

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Chaparro. A scholar is included among the top collaborators of Cecilia Chaparro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Chaparro. Cecilia Chaparro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sykes, Jenna, Stephanie Y. Cheng, Meghan Aversa, et al.. (2025). The Changing Transplant Landscape in the Era of Elexacaftor/Tezacaftor/Ivacaftor: A Word of Caution. Clinical Transplantation. 39(10). e70317–e70317.

Goldstein, Roger, Lisa Wickerson, Shaf Keshavjee, et al.. (2025). Exploring the effects of pulmonary rehabilitation and its determinants in lung transplant candidates with cystic fibrosis. Respiratory Medicine. 239. 107982–107982. 1 indexed citations

Walti, Laura N., Simran Kaur, Tony Mazzulli, et al.. (2025). Serum Ammonia Screening and Donor Mollicutes Detection for Hyperammonemia Syndrome Post–Lung Transplantation: A Prospective Observational Study. Clinical Infectious Diseases. 81(5). 998–1004.

Tile, Lianne, Chung‐Wai Chow, Heather McDonald-Blumer, et al.. (2025). Lung transplantation and bone health: A narrative review. The Journal of Heart and Lung Transplantation. 44(6). 849–857. 1 indexed citations

Luong, Me‐Linh, Fernanda P. Silveira, C. Orla Morrissey, et al.. (2024). Management of infectious disease syndromes in thoracic organ transplants and mechanical circulatory device recipients: a Delphi panel. Transplant Infectious Disease. 26(3). e14251–e14251. 2 indexed citations

McKone, Edward F., Kathleen J. Ramos, Cecilia Chaparro, et al.. (2023). Position paper: Models of post-transplant care for individuals with cystic fibrosis. Journal of Cystic Fibrosis. 22(3). 374–380. 6 indexed citations

Ramendra, Rayoun, Ella Huszti, Meghan Aversa, et al.. (2023). Oesophageal stasis is a risk factor for chronic lung allograft dysfunction and allograft failure in lung transplant recipients. ERJ Open Research. 9(5). 222–2023. 2 indexed citations

Dias, Olívia Meira, Nadia Sharif, L.G. Singer, et al.. (2022). Strongyloides hyper-infection in a lung transplant recipient: Case report and review of the literature. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 7(2). 150–156. 3 indexed citations

Koutsokera, Angela, Jenna Sykes, Olga Theou, et al.. (2022). Frailty predicts outcomes in cystic fibrosis patients listed for lung transplantation. The Journal of Heart and Lung Transplantation. 41(11). 1617–1627. 13 indexed citations

10.

Herrera, Sabina, L.G. Singer, Matthew Binnie, et al.. (2020). Extending cytomegalovirus prophylaxis in high‐risk (D+/R−) lung transplant recipients from 6 to 9 months reduces cytomegalovirus disease: A retrospective study. Transplant Infectious Disease. 22(4). e13277–e13277. 11 indexed citations

11.

Law, Nancy, Bassem Hamandi, Christine Fegbeutel, et al.. (2019). Lack of association of Aspergillus colonization with the development of bronchiolitis obliterans syndrome in lung transplant recipients: An international cohort study. The Journal of Heart and Lung Transplantation. 38(9). 963–971. 10 indexed citations

12.

Hirama, Takashi, et al.. (2019). Pulmonary Blastomycosis Following Eculizumab Therapy in a Lung Transplant Recipient. Experimental and Clinical Transplantation. 18(3). 410–413. 4 indexed citations

13.

Tikkanen, Jussi, L.G. Singer, Yanhong Li, et al.. (2016). De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation. American Journal of Respiratory and Critical Care Medicine. 194(5). 596–606. 132 indexed citations

14.

Cypel, Marcelo, Jonathan Yeung, Mingyao Liu, et al.. (2011). Normothermic Ex Vivo Lung Perfusion in Clinical Lung Transplantation. New England Journal of Medicine. 364(15). 1431–1440. 739 indexed citations breakdown →

15.

Al-Faifi, Salem M., Cecilia Chaparro, Thomas K. Waddell, et al.. (2007). The Effect of Recipient’s Age on Lung Transplant Outcome. American Journal of Transplantation. 7(5). 1271–1277. 63 indexed citations

16.

Sarahrudi, Kambiz, Marc Estenne, Paul A. Corris, et al.. (2004). International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection. Journal of Thoracic and Cardiovascular Surgery. 127(4). 1126–1132. 68 indexed citations

17.

Perrot, Marc de, Cecilia Chaparro, Karen McRae, et al.. (2004). Twenty-year experience of lung transplantation at a single center: influence of recipient diagnosis on long-term survival. Journal of Thoracic and Cardiovascular Surgery. 127(5). 1493–1501. 104 indexed citations

18.

Chaparro, Cecilia, J.R. Maurer, Carlos Cano, et al.. (2001). Infection with Burkholderia cepacia in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 163(1). 43–48. 183 indexed citations

19.

Kesten, Steven, Masina Scavuzzo, Cecilia Chaparro, & John‐Paul Szalai. (1998). Pharmacokinetic Profile and Variability of Cyclosporine versus Neoral in Patients with Cystic Fibrosis after Lung Transplantation. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(4). 847–850. 14 indexed citations

20.

Herridge, Margaret S., Alberto L. de Hoyos, Cecilia Chaparro, et al.. (1995). Pleural complications in lung transplant recipients. Journal of Thoracic and Cardiovascular Surgery. 110(1). 22–26. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact